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Allergic contact dermatitis is a T cell-mediated delayed
type hypersensitivity reaction that occurs upon hapten
challenge in sensitized individuals. The in£ammatory
response in classical allergic contact dermatitis requires
both a sensitization phase and an elicitation phase re-
sponsible for the recruitment and activation of speci¢c
T cells at the site of hapten skin challenge. Conversely,
previously unsensitized patients may develop a ‘‘pri-
mary allergic contact dermatitis’’ after the ¢rst skin
contact with potent contact sensitizers leading to a skin
in£ammation with all the features of classical allergic
contact dermatitis. In this study we used an experimental
murine model, referred to as contact hypersensitivity,
to study the pathophysiology of primary allergic con-
tact dermatitis and its relationship to classical allergic
contact dermatitis. We show that one epicutaneous
application of a nonirritant dose of hapten (2,4-dini-
tro£uorobenzene, £uorescein isothiocyanate) was su⁄-
cient to induce an optimal allergic contact dermatitis
reaction at the site of primary contact with the hapten
without subsequent challenge. As in classical allergic
contact dermatitis, the skin in£ammation in primary
allergic contact dermatitis was mediated by interferon-
c producing, CD8þ e¡ector Tcells that were induced in
the draining lymph nodes at day 5 postsensitization and
downregulated by CD4þ Tcells. Reverse transcription^
polymerase chain reaction analysis revealed that the
primary allergic contact dermatitis reaction was
mediated by a recruitment of CD8þ Tcells at the sensi-
tization skin site at day 6 postsensitization. Analysis of
the fate of the hapten £uorescein isothiocyanate applied
once on the skin revealed its persistence in the epider-
mis for up to 14 d after skin painting. These results sug-
gest that the development of primary allergic contact
dermatitis (i.e., without secondary challenge) is asso-
ciated with persistence of the hapten in the skin, which
allows the recruitment and activation of CD8þ T cells
at the site of the single hapten application. Key words:
contact hypersensitivity/hapten persistence/leukocyte tra⁄ck-
ing/skin. J Invest Dermatol 120:641 ^647, 2003
A
llergic contact dermatitis (ACD), one of the most
common skin diseases with a great socio-economic
impact, is a T cell-mediated in£ammatory reaction
occurring at the site of challenge with a contact al-
lergen (hapten) in sensitized individuals (Krasteva
et al, 1999a). Knowledge of the pathophysiology of ACD is de-
rived chie£y from animal models in which the skin in£ammation
induced by hapten painting of the skin is referred to as contact
hypersensitivity (CHS) (Garrigue et al, 1994; Van Der Valk,
2002). ACD and CHS are thus considered as synonymous and
de¢ne a hapten-speci¢c T cell-mediated skin in£ammation. They
represent a form of delayed type hypersensitivity reactions. As in
all delayed type hypersensitivity reactions, the pathophysiology
of ACD consists classically of two distinct phases, i.e., the
sensitization and the elicitation phases, which are considered to
be temporally and spatially dissociated (Enk and Katz, 1995;
Grabbe and Schwarz, 1998; Krasteva et al, 1999b; Cavani et al,
2001). The sensitization phase (also referred to as the a¡erent
phase of ACD) occurs at the ¢rst contact of skin with the hapten.
Hapten is taken up by skin dendritic cells (DC) that migrate to
the draining lymph nodes (LN), where they present haptenated
peptides on major histocompatibility complex class I and II mo-
lecules resulting in the induction of hapten-speci¢c CD8þ and
CD4þ T cells, respectively (Bour et al, 1995; Krasteva et al, 1997).
The sensitization step lasts 8^15 d in humans, 5^7 d in the mouse,
and is thought to have no clinical consequence. The elicitation
phase, also known as e¡erent phase or challenge phase of CHS.
Challenge with the same hapten in sensitized individuals leads
in a few hours to the appearance of ACD. Upon subsequent con-
tacts of the skin with the hapten, e¡ector T lymphocytes are
recruited and activated in the dermis, and trigger the in£amma-
tory process responsible for the cutaneous lesions. This e¡erent
phase of CHS takes 72 h in humans, and 24^48 h in the mouse.
The in£ammatory reaction persists during several days and
progressively decreases upon physiologic downregulating
mechanisms. Although in some experimental systems CD4þ
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Tcells have been shown to mediate the CHS responses (Gocinski
and Tigelaar, 1990; Wang B et al, 2000), recent data from our la-
boratory and others pointed to the major role of CD8þ Tcells as
e¡ector cells in CHS to di¡erent haptens (Bour et al, 1995; Xu
et al, 1996; Bouloc et al, 1998; Cavani et al, 2001). Indeed, CHS to
2,4 -dinitro-£uorobenezene (DNFB) is mediated by CD8þ cyto-
toxic T lymphocytes (CTL), generated in the lymphoid organs
during the sensitization phase and rapidly recruited into the skin
after challenge where they induce ACD through cytotoxicity
(Kehren et al, 1999; Akiba et al, 2002). In¢ltration of challenged
skin by CD8þ Tcells was associated with keratinocyte apoptosis,
suggesting that epidermal cells were the cell target of speci¢c
CD8þ CTL. Conversely, CD4þ T cells, in this model, were
downregulating the in£ammatory reaction as, in their absence,
the ACD reaction was increased and prolonged (Gocinski and
Tigelaar, 1990; Bour et al, 1995; Bouloc et al, 1998).
Although it has been postulated that ACD is elicited by hapten
exposure in sensitized individuals, clinical evidence has demon-
strated that ‘‘primary ACD’’ could develop in previously unsensi-
tized patients. These reactions, known as ‘‘primary allergic
reactions’’ or ‘‘active sensitization’’ develop 7^15 d after skin con-
tact with potent contact sensitizers such as DNFB/dinitrochloro-
benzene, urushiol, and primine (Adams and Fischer, 1990;
Kanerva et al, 1994; Vigan et al, 1997). The eczematous lesions are
morphologically indistinguishable from conventional ACD and
have the same kinetics in the ampli¢cation and the spontaneous
regression of skin in£ammation, suggesting that similar e¡ector
and downregulatory mechanisms are involved in classical and
primary ACD; however, the relationship between primary and
classical ACD has never been ¢rmly established. In order to get
a better insight into the mechanisms of induction of skin in£am-
mation in primary ACD, we have developed a mouse model in
which a single topical application of the strong haptens DNFB
and £uorescein isothiocyanate (FITC) elicit an ACD response.
We show that the pathophysiology of one-step primary ACD is
identical to that of two-step classical ACD and involves CD8þ
e¡ector Tcells primed in the draining LN and recruited at the site
of primary sensitization. Use of FITC to follow the hapten fate
shows its persistence in epidermal cells for as long as 14 d after a
single skin application. Our mouse model provides evidence that
primary allergic reactions are elicited and downregulated by im-
mune mechanisms similar to those of ACD in sensitized subjects,
allowing them to be called ‘‘primaryACD’’.
MATERIALS AND METHODS
Mice Female BALB/C mice, 6 wk old, were purchased from I¡a-Credo
(L’Arbresle, France). Animals were left to acclimate for 1wk before entering
the study. Five mice were used per group. Mice were housed individually
and were provided food and water ad libidum.
Reagents DNFB (Sigma, St Louis, MO) and 4-ethoxy-methylene-2-
phenyloxazol-5-one (oxazolone; Aldrich, Milwaukee, WI) were diluted
in acetone/olive oil (4 : 1). FITC (Sigma) was diluted in acetone/
dibutylphthalate (1 : 1). Haptens were freshly prepared before application.
Assay for murine ACD: the mouse ear swelling test
Assay for classical ACD The original procedure of the mouse ear swelling
test has been described in detail elsewhere (Garrigue et al, 1994; Bour et al,
1995) and is summarized Fig 1(A). Brie£y, mice were sensitized by epicu-
taneous application of haptens on to 2 cm2 of fur-shaved dorsal skin at an
irritant concentration of either 0.5% of DNFB or 2% of oxazolone diluted
in acetone/olive oil (4 : 1; 25 ml). Five days later, animals were challenged on
the ear by a nonirritant concentration of 0.2% of DNFB or 0.3% of oxa-
zolone diluted in acetone/olive oil (4 : 1; 5 ml) applied on to each side of one
ear, whereas the same volume of vehicle was applied on the contralateral
ear. FITC was applied at 0.5% concentration both for sensitization (40 ml)
and for challenge (2 5 ml) on each side of one ear. Ear thickness measure-
ments were taken for each ear prior to hapten application with a
spring-loaded micrometer (J15, Blet SA, Lyon, France). Measurements were
repeated once daily after challenge. Ear swelling was calculated by
subtracting the initial value from the value recorded on the corresponding
day, and further subtracting any swelling recorded for the vehicle-control
ear from the swelling recorded for the hapten-challenged ear.
Assay for primaryACD Naive mice were sensitized by a single application
of a nonirritant concentration of haptens (DNFB 0.2%, oxazolone 0.3%,
and FITC 0.5%) on to the left ear, whereas the right ear was painted with
an equal volume of vehicle. The protocol is summarized in Fig 1(B). At
various times after ear sensitization, ear thickness was measured and ear
swelling calculated as described for the classical murine ACD reaction.
RNA extraction and reverse transcription-polymerase chain
reaction (reverse transcription-PCR) analysis of CD8 and
interferon (IFN)-g mRNA At di¡erent intervals after challenge
(classical ACD) or sensitization (primary ACD), ear samples were
collected from sensitized or unsensitized mice and frozen in liquid
nitrogen. The detection of RNA was conducted as described in detail
elsewhere (Delassus et al, 1994). In brief, total RNA was extracted using
the RNAXEL kit (Eurobio, F-91953, Lesulis, France). After DNase I
treatment, 1 mg of total RNA was reverse transcribed using poly dT15
primers and Superscript II reverse transcriptase (90 min, 371C; Gibco
BRL) (Invitrogen, F95613, Cergy Pontoise). The amount of RNA to
be used for detection was normalized using the housekeeping gene
hypoxanthine phosphoribosyltransferase as reference. The cDNA obtained
was ampli¢ed using di¡erent sets of primers:
For hypoxanthine phosphoribosyltransferase: 50 primer, 50 -GTA ATG
ATC AGT CAA CGG GGG AC-30; 30 primer, 50 -CCA GCA AGC TTG
CAACCT TAACCA-30
For CD8: 50 primer, 50 -AGG ATG CTC TTG GCT CTT CC-30; 30
primer, 50 -TCA CAG GCG AAG TCC AAT CC-30
For IFN-g: 50 primer, 50 -GCT CTG AGA CAA TGA ACG CT-30; 30
primer, 50 -AAA GAG ATA ATC TGG CTC TGC-30.
The ampli¢cations were carried out with 29 cycles for hypoxanthine
phosphoribosyltransferase and 33 cycles for IFN-g and CD8 (1 min at
941C, 1min 30 s at 601C, 2min at 721C). The PCR products were
analyzed on 1.5% agarose gel.
IFN-g Enzyme-linked Immunospot Assay (ELISPOT) Inguinal
plus axillary (classical ACD) or auricular (primary ACD) draining LN
were harvested 5 d after DNFB sensitization. The number of IFN-g-
producing cells was determined using an ELISPOT assay. In brief, 96-well
nitrocellulose plates (MAHA 45; Millipore) (Millipore, F-78054, ST.
Quentin en Yuelines) were coated overnight at 41C with anti-IFN-g-
antibody (R46A2) and blocked with phosphate-bu¡ered saline (PBS)/1%
bovine serum albumin for 2 h at 371C. The plate were washed three times
with PBS/Tween 0.1% before use. The LN cell suspensions were incubated
Figure1. Kinetics of the in£ammatory response to DNFB during
classical ACD and primary ACD. (A) In£ammatory response in sensi-
tized and challenged mice (classical ACD). Mice were sensitized by skin
painting with DNFB 0.5% on the shaved back skin. Five days later they
were ear challenged with DNFB 0.2% () or oxazolone 0.3% (’). (B) In-
£ammatory response induced by a single hapten application (primary
ACD). Unsensitized mice were ear painted with DNFB 0.2% (). Results
are expressed as the mean ear swelling at di¡erent time points after chal-
lenge and are representative of three independent experiments.
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with 0.4mM of DNBS directly on the plates overnight at 371C, 5% CO2.
Plates were washed three times with PBS/Tween 0.1% and incubated 2 h at
room temperature with a biotinylated anti-IFN-g-antibody (XMG1.2) and
extensively washed. IFN-g spot-forming cells were developed using
streptavidin^alkaline phosphatase (Boehringer Mannheim), incubated for 2 h
at room temperature, and extensively washed before adding the substrate (5-
bromo-4-chloro-3-indolyl-phosphate; Sigma). The number of IFN-g spot-
forming cells present in each well was counted using the Carl Zeiss vision
ELISPOT (Carl Zeiss Vision, D-85399, Hallberghoos, Germany) and the
results were expressed as IFN-g spot-forming cells/105 LN cells.
In vivo depletion of CD4þ and CD8þ T cells The rat anti-mouse
CD4 monoclonal antibody (MoAb) GK 1.5 (Kehren et al, 1999) was
obtained from the American Type Culture Collection (Rockville, MD)
and the rat anti-mouse CD8 MoAb H35.17.2 (Akiba et al, 2002) was
kindly provided by G. Milon (Institut Pasteur, Paris). Mice were given i.p.
injections of 200 ml of anti-CD4 or anti-CD8 MoAb as 1 : 20 dilution of
ascites on days ^1, 0,þ1, andþ 4 of skin sensitization. Cell depletion was
assessed in each mouse by staining peripheral blood mononuclear cells
drawn from the tail vein, using FITC- or phycoerythrin-labeled anti-
CD4 or anti-CD8 MoAb (Tebu, Le Perray-en-Yvelines, France).
Immunohistochemical analysis of epidermal sheets Epidermis from
the challenged ears was peeled o¡ the connective tissue by incubation
for 1h at 371C in PBS supplemented with ethylenediamine tetraacetic
acid 20mM (Sigma). The sheets were cut into small pieces, rinsed, and
incubated overnight at 41C with rat IgG2b anti-mouse Ia (clone CD311)
or isotype-matched irrelevant antibody. After three washes in PBS/1%
bovine serum albumin, the sheets were incubated for 30min at room
temperature with biotinylated F(ab0)2 fragment of goat antibodies speci¢c
for rat IgG (Hþ L) (Pierce, Interchim, MontlucG on, France), washed, and
then further incubated with streptavidin conjugated to peroxidase (ABC
kit, Dako, Carpinteria, CA). The reaction was developed using 3-amino-
9-ethylcarbazole (AEC) substrate and H2O2 (Dako).
RESULTS
PrimaryACD can develop after a single hapten exposure in
unsensitized mice The classical murine model of the ACD
Figure 2. Hapten speci¢city of the in£ammatory reaction induced
in primaryACD. DNFB 0.2% () or oxazolone 0.3% (’) were applied
on the right ear of mice that, 30 d previously, have developed a primary
ACD following skin application of DNFB 0.2% on the left ear.
Figure 3. E¡ect of CD4þ and CD8þ Tcell depletion on the primaryACD reaction. (A) Mice were subjected either to the classical ACD (left panel)
assay or to the primaryACD assay (right panel). CD4þ Tcell-depleted (), CD8þ T cell-depleted (m) and untreated mice (’) from both groups were ear
painted simultaneously with DNFB 0.2% at day 0. Results are expressed as the mean ear swelling at di¡erent time points after challenge. (B) Histologic
analysis of the skin in£ammatory reaction in primaryACD. Mice were ear painted with DNFB 0.2% at day 0 (as in A). Biopsies were taken at day 6. (B1)
Typical histology of ACD reaction in DNFB sensitized, untreated mice. (B2) Exaggerated in£ammatory skin reaction in CD4þ T cell-depleted mice,
including enhanced edema, vasodilatation and prominent mononuclear cell in¢ltration. (B3) Lack of skin in£ammation in CD8þ T cell-depleted mice.
HES staining; original magni¢cation 40.
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reaction requires two applications of the hapten. Application
of DNFB on the ears of previously sensitized mice induces
an ear swelling that peaks 24^48 h postchallenge and then
rapidly decreases (Fig 1A). An irrelevant hapten (oxazolone)
applied on the ear of DNFB-sensitized mice fails to produce
a classical ear swelling response at 24^48 h, thus demonstrating
the hapten speci¢city of the in£ammatory reaction (Fig 1A).
Interestingly, these DNFB-sensitized, oxazolone-challenged
mice developed a delayed skin in£ammatory reaction at the site
of challenge with kinetics comparable with that observed in
ACD. This reaction, which has been previously described and
referred to as ‘‘primary immune response to cutaneous antigens’’
(Williams et al, 1994), corresponds to a primary ACD that is
studied in detail below.
Primary ACD is obtained by application of DNFB on the ear
of unsensitized mice, which induced an in£ammatory reaction
starting at day 6, peaking at days 7^8 and quickly subsiding
thereafter (Fig 1B). The magnitude of primary ACD is similar
to that of classical ACD but has a di¡erent kinetic since the
onset of the skin in£ammation is delayed by 5 d. This period
might correspond to the time required to achieve T cell priming
(Macatonia et al, 1986; Kripke et al, 1990). Challenge with DNFB
on the contralateral ear 30 d later induced a classical ACD with
ear swelling peaking at 24 h, con¢rming that the initial
in£ammatory reaction was responsible for the generation of
immunologic memory (Fig 2). Alternatively, challenge with an
irrelevant hapten (i.e., oxazolone 0.3%) did not induce any in£am-
matory response in the DNFB-sensitized mice, demonstrating
that primary ACD is a hapten-speci¢c in£ammatory reaction
(Fig 2).
Primary ACD is mediated by CD8þ e¡ector T cells and
downregulated by CD4þ T cells We have previously shown
that CD8þ CTL were e¡ector cells in CHS reactions to DNFB
in BALB/C mice (Bour et al, 1995). In order to analyze the
contribution of CD8þ and CD4þ T cells in the primary ACD
reaction, mice were depleted in CD4þ or CD8þ T cells by
treatment with speci¢c MoAb. In both classical ACD (Fig 3A,
left) and primary ACD (Fig 3A, right), CD8þ T cell depletion
totally abolished the in£ammatory response, whereas CD4þ T
cell depletion yielded to enhanced and sustained skin in£am-
mation. Histologic examination of the ears of DNFB-sensitized,
but untreated mice, at the peak of the skin in£ammation (i.e., at
day 6 after skin painting) showed that the ear swelling in primary
ACD was associated with dermal edema, vascular enlargement,
and mononuclear cell in¢ltration (Fig 3B1). These changes were
similar to those observed in classical murine ACD (not shown).
Primary ACD induced in CD4þ T cell-depleted mice resulted
in a dramatic increase in dermal thickness, which was due to
edema, vascular enlargement, and massive in¢ltration of
mononuclear cells (Fig 3B2). In contrast, CD8þ T cell-depleted
mice exhibited a normal skin histology, undistinguishable from
that of naive untreated mice (Fig 3B3). Thus, T cell involvement
in primaryACD to DNFB is similar to that observed in classical
ACD and comprises CD8þ e¡ector T cells and CD4þ
downregulatoryT cells.
Studies of the a¡erent and e¡erent phase of primary
ACD The pathophysiology of classical ACD is well-known
and requires two temporally dissociated steps: the a¡erent phase
(sensitization) and the e¡erent phase (elicitation). In order to get
insight into the pathophysiology of primaryACDwe next analyzed
the a¡erent and e¡erent phases involved in the generation of
hapten-speci¢c in£ammation following a single skin contact
with DNFB.
We ¢rst studied the mechanisms of T cell priming occurring
during the a¡erent phase in primary ACD. BALB/C mice
were sensitized with DNFB in the classical or primary ACD
model and lymphoid cells of the draining LN (inguinal
plus axillary LN and auricular LN, respectively) were recovered
5 d later and tested in an ELISPOT assay to determine
the frequency of DNFB-speci¢c, IFN-g-producing LN cells.
As previously shown, in this system, IFN-g production is
restricted to CD8þ e¡ector T cells (Xu et al, 1996; Kehren et al,
1999). Figure 4A shows that the frequency of DNFB-speci¢c,
IFN-g-producing T cells was equivalent in the primary and
classical ACD reactions, demonstrating that application of
hapten on the ear led to e⁄cient T cell priming in auricular
draining LN.
Study of the e¡erent phase of CHS was done by analyzing the
recruitment of IFN-g-producing CD8þ Tcells in the ear skin at
days 4, 5, and 6 after ear skin sensitization. We have previously
shown that recruitment of CD8þ T cells could be followed by
reverse transcription-PCR for CD8 and IFN-g mRNA (Kehren
et al, 1999; Akiba et al, 2002). In classical ACD, CD8þ T cells
in¢ltrate the skin early after hapten challenge and are maximal
24/48 h postchallenge (Akiba et al, 2002; Fig 4B). In primary
ACD, PCR analysis showed that CD8 and IFN-g mRNAwere
neither found in the skin of nave mice nor in the ears at days 3 or
4 after hapten painting. In contrast, upregulation of both CD8
and IFN-g mRNA occurred at day 5 and were maximum at day
6 (Fig 4B).
These data indicate that the mechanisms involved in the
generation of primary ACD are identical to those involved in
classical ACD and comprise temporally dissociated a¡erent and
e¡erent phases.
Figure 4. Priming of speci¢c Tcells in draining LN and their subse-
quent recruitment in haptenized skin in primary and classical
ACD. (A) DNBS-speci¢c IFN-g spot-forming cells in LN from DNFB-
sensitized BALB/C mice in the classical or primaryACD model after over-
night restimulation with (black bars) or without (white bars) DNBS. (B) De-
tection of CD8 and IFN-g mRNA in the ear skin during classical and
primary ACD. CD8 and IFN-g mRNA expression in situ was analyzed
using semiquantitative reverse transcription-PCR; mRNA was obtained
from the ear of mice at days 1 and 2 postchallenge in classical ACD and at
days 4, 5, and 6 post ear sensitization. Controls included ears of untreated
(nave) and ears of unsensitized but challenged mice.
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Primary ACD is associated with hapten persistence in the
skin The observation that primary ACD developed 6^7 d after
a single skin painting with DNFB and resolved after days 9^12
suggested that the hapten persisted in the skin for at least 7 d. In
order to test this hypothesis, the £uorescent hapten FITC was
used to examine both the fate of hapten in the skin and the
induction of FITC-speci¢c ACD.
We ¢rst observed that the hapten FITC induced a classical
ACD (Fig 5A) (sensitization on the back skin at day 0 and
challenge on the ear skin at day 5) as well as a primary ACD
(single application of FITC at day 0 on the ear) (Fig 5B).We next
followed the distribution of FITC in the epidermis at various time
points after the single hapten application on the ear skin.
Epi£uorescence examination of epidermal sheets revealed FITC
persistence for up to 14 d. Large areas of con£uent brightly
£uorescent epidermal cells, with morphologic features of
keratinocytes were observed at 24 h after FITC painting (Fig 5C)
and were still present at day 6 (Fig 5D). From day 6, the number
of FITCþ cells and the £uorescence intensity of individual cells
declined, leading to a pattern of perifollicular staining, which was
observed up to day 14 (Fig 5E). Double staining of epidermal
sheets using anti-Ia MoAb showed that, at day 9 post-FITC
painting, FITCþ cells comprised mostly keratinocytes and that
only a limited number of major histocompatibility complex
class IIþ Langerhans cells had taken up the hapten (Fig 5F).
Thus, our results show that primary ACD, which is associated
with the recruitment of e¡ector T cells at the site of the initial
contact with hapten, is due to the persistence of the hapten in
the skin.
DISCUSSION
It has been postulated that ACD in humans is elicited by hapten
exposure in a previously sensitized individual; however, ‘‘primary
allergic reactions’’characterized by lesions appearing 10^14 d after
either skin contact with dinitrochlorobenzene or patch testing
with other strong contact allergens have been reported in patients
who have never been exposed before (Adams and Fischer, 1990;
Kanerva et al, 1994;Vigan et al, 1997). In this study we have devel-
oped a murine model of primaryACD, which demonstrates that
a hapten-speci¢c skin in£ammation can develop in naive mice
within 7 d after a single epicutaneous exposure to strong contact
sensitizers, including DNFB and FITC. This immune response
was hapten-speci¢c, induced immunologic memory and exhib-
ited immunologic features similar to those observed in classical
ACD, which develops in previously sensitized mice upon hapten
challenge. The kinetics of the skin in£ammation (bell-curve
shape) as well the intensity of the ear swelling was similar to that
of classical ACD.
The a¡erent phase of primaryACD was, as expected, similar to
that of classical ACD, despite di¡erences in the protocol of sensi-
tization concerning the site of sensitization and dose of hapten
used. The sensitization site was the back or abdominal skin in
classical ACD and the ear skin in primaryACD.The dose of hap-
ten was lower in primary ACD and did not induce a clinical
irritant in£ammatory reaction as assessed by the lack of ear swel-
ling 24 h after skin painting. Primary ACD is mediated by
hapten-speci¢c CD8þ T cells, which are primed in the draining
auricular LN by skin migrating DC. In primary ACD, hapten
Figure 5. Primary ACD reaction to FITC is associated with persistence of the hapten in the skin. Kinetics of the classical (A) and primary (B)
ACD to FITC. Mice were either sensitized by applying FITC 0.5% on the back skin at day ^ 5 (A) or unsensitized prior to ear painting (B). Both experi-
mental groups were ear painted simultaneously at day 0, by application of FITC 0.5% on the left ear. Results are expressed as the mean ear swelling at
di¡erent time points after challenge and are representative of three independent experiments. Immunohistochemical analysis of epidermal sheets showing
FITC staining of epidermal cells at 24 h (C), day 6 (D), and day 14 (E) after ear painting. Staining of epidermal sheets with CD311 (anti-Ia) monoclonal
antibody at day 9 after ear painting (F) showed that FITC staining was mostly found on Ia^ epidermal cells. Double-stained epidermal cells with dendritic
cell morphology, presumably Langerhans cells, comprised only a minority of FITC-positive epidermal cells (original magni¢cation100 for C^E; 250
for F).
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(FITC)-loaded skin DC were found in the draining auricular LN
24 h after ear skin painting and expressed markers of mature DC,
similar to what is observed in classical ACD (data not shown)
(Macatonia et al, 1987). It is noteworthy that ear priming gave rise
5 d after skin painting to the same number of hapten-speci¢c
CD8þ T cells/LN as regular sensitization on the abdominal or
back skin.
Studies of the development of the primary ACD reaction de-
monstrated that the e¡erent phase of ACD could develop in the
absence of challenge. In classical ACD, the recruitment in the skin
and the subsequent activation of speci¢c e¡ector T cells is mea-
sured at the site of the challenge, which is distant from the site
of sensitization. Application of the hapten on the ear skin in sen-
sitized mice induces activation of innate skin immune cells, espe-
cially keratinocytes and endothelial cells, leading to synthesis of
proin£ammatory cytokines, chemokines, and expression of adhe-
sion molecules by endothelial cells (Enk and Katz, 1992). The lat-
ter allow the recruitment at the challenged site of T cells bearing
appropriate homing receptors, including CD8þ T cells, which
have emigrated from the LN and tra⁄c through the blood
(Robert and Kupper, 1999). Recruitment of e¡ector T cells at the
site of hapten painting was demonstrated in the primaryACD by
reverse transcription-PCR analysis of CD8 mRNA, which was
previously shown to correlate with the degree of in¢ltration of
CD8þ T cells during the elicitation phase of CHS (Akiba et al,
2002). CD8þ Tcells could be found neither in naive skin nor in
the skin 4 d after hapten painting. CD8þ T cells started to in¢l-
trate the skin at day 5. This implies that the minimal time be-
tween sensitization and ability of e¡ector cells to be recruited in
the skin is 5 d. Interestingly, our results suggest that the in£am-
matory reaction induced by the pro-in£ammatory properties of
haptens, which is required for the recruitment of leukocytes in a
tissue, is still present 5 d after skin painting. Activation of e¡ector
T cells was monitored by reverse transcription^PCR for IFN-g,
whose production in this system is restricted to CD8þ T cells
(Xu et al, 1996; Kehren et al, 1999; Akiba et al, 2001). Results pro-
vided evidence that in¢ltrating CD8þ T cells in primary ACD
were activated in situ and produced IFN-g. Thus this new proto-
col could be of relevant interest to study the skin T cells recruit-
ment and activation.
The nature of the skin cell able to present haptenated peptides
to speci¢c T cells and to induce their activation is still a matter of
debate. Although DC are undoubtedly involved in hapten pre-
sentation during the sensitization phase of ACD, their role during
the elicitation phase is unclear. As, in our system, CD8 e¡ector T
cells are restricted to major histocompatibility complex class I
molecules (Bour et al, 1995; Bouloc et al, 1998), all major histo-
compatibility complex class I-expressing skin cells could be in-
volved in hapten presentation. In this respect, we have recently
shown, in murine models of ACD, that keratinocytes were the
main target of CD8þ CTL during the elicitation phase of CHS
with early apoptosis of epidermal basal cells paralleling CD8þ T
cell in¢ltration. These data, which are in agreement with studies
on human ACD (Trautmann et al, 2000), suggested that keratino-
cytes were the main hapten-presenting cells in ACD with two
pathophysiologic consequences, i.e., activation of CD8þ CTL
and induction of keratinocyte apoptosis. Using FITC-speci¢c
primaryACD we could show that capture of FITC by epidermal
cells and its retention in the skin for several days (up to day 14
after single painting) most likely accounts for the ability to devel-
op skin in£ammation at the site of primary contact even in the
absence of secondary exposure. Hapten persistence allowed the
two major events necessary for the development of the e¡erent
phase of CHS: (i) recruitment of T cells in the skin under the
control of in£ammatory signals induced by the hapten, and (ii)
activation of e¡ector cells by hapten-presenting cells, implying
that the hapten is present in an immunogenic form.
Our data illustrate the role of CD4þ Tcell-mediated downre-
gulation of antigen-speci¢c skin in£ammation (Xu et al, 1996;
Biedermann et al, 2001; Gorbachev and Fairchild, 2001). Indeed,
mice de¢cient in CD4þ T cells mounted an exaggerated and
sustained primaryACD reaction, which was associated with mas-
sive skin in¢ltration with mononuclear cells, consistent with a
chronic activation of CD8þ e¡ector cells. It is somehow surpris-
ing that, in normal mice, downregulation of skin in£ammation
started on day 8 after skin painting and was completed by day
12 despite persistence of the hapten in the epidermis. This sug-
gests that the mechanisms involved in triggering the regulatory
pathway does not preclude complete elimination of the hapten
from the skin. The precise mechanisms whereby CD4þ T cells
exert their regulatory activity is not known (Biedermann et al,
2001; Bour et al, 1997).We have previously shown that haptenated
DC are able to prime both hapten-speci¢c CD8þ and CD4þ T
cells and that regulation of ACD may be induced by adoptive
transfer of haptenated IIþ I^ DC before epicutaneous sensitiza-
tion in normal mice (Grabbe and Schwarz, 1998). It is thus possi-
ble that CD4þ T cells primed with the hapten in lymphoid
organs regulate expansion and/or function of CD8þ e¡ectors
through as yet unidenti¢ed mechanisms that may include apop-
tosis through Fas/Fas ligand interaction (Piazza et al, 1997) or pro-
duction of anti-proliferative cytokines (Fiorentino et al, 1991; Berg
et al, 1995).
In conclusion, a¡erent and e¡erent phases of hapten-speci¢c
skin in£ammation can be induced after a single skin contact with
haptens, due to persistence of the hapten in the skin for long per-
iods of time. The ¢nding that the regulation of the allergic re-
sponse occurs despite continuous presence of the hapten in the
skin suggests that this model could be useful for understanding
the mechanisms involved in the regulation of antigen-speci¢c in-
£ammatory responses.
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